Links

Tools

Export citation

Search in Google Scholar

Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib affect oxidation of an anticancer drug ellipticine by cytochromes P450 but not by peroxidases

Journal article published in 2018 by R. Indra ORCID, M. Kolarik, M. Stiborova
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload